The Effect of Endothelin Receptor Antagonists in Patients with Eisenmenger Syndrome: A Systematic Review.

about

The Effect of Endothelin Receptor Antagonists in Patients with Eisenmenger Syndrome: A Systematic Review.

Item

http://www.wikidata.org/entity/Q38992606

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

The Effect of Endothelin Recep ...... Syndrome: A Systematic Review.

@en

type

Item

label

The Effect of Endothelin Recep ...... Syndrome: A Systematic Review.

@en

prefLabel

The Effect of Endothelin Recep ...... Syndrome: A Systematic Review.

@en

P1476

The Effect of Endothelin Recep ...... Syndrome: A Systematic Review.

@en

P2093

Abdelrahman Elshafay

http://www.w3.org/2001/XMLSchema#string

Duy Hieu Truong

http://www.w3.org/2001/XMLSchema#string

Hatem G Metwali

http://www.w3.org/2001/XMLSchema#string

Hossam Idrees

http://www.w3.org/2001/XMLSchema#string

Mohamed M AboElnas

http://www.w3.org/2001/XMLSchema#string

Nguyen Lam Vuong

http://www.w3.org/2001/XMLSchema#string

Omar Ahmed Saad

http://www.w3.org/2001/XMLSchema#string

P2860

Endothelin receptor antagonists for pulmonary arterial hypertension

Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

Current therapy and outcome of Eisenmenger syndrome: data of the German National Register for congenital heart defects

The Adult Patient with Eisenmenger Syndrome: A Medical Update after Dana Point Part III: Specific Management and Surgical Aspects.

Eisenmenger's syndrome: current management.

Acute endothelin A receptor antagonism improves pulmonary and systemic haemodynamics in patients with pulmonary arterial hypertension that is primary or autoimmune and related to congenital heart disease

Effect of the oral endothelin antagonist bosentan on the clinical, exercise, and haemodynamic status of patients with pulmonary arterial hypertension related to congenital heart disease.

Pulmonary arterial hypertension in adults with congenital heart disease: distinct differences from other causes of pulmonary arterial hypertension and management implications.

P2888

s40256-017-0240-5

P304

93-102

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40256-017-0240-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090285187

http://www.w3.org/2001/XMLSchema#string

P698

28660556

http://www.w3.org/2001/XMLSchema#string